medigraphic.com
ISSN 1405-1710 (Print)

2024, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2024; 33 (1)

Primary cutaneous diffuse large B-cell lymphoma

Jiménez-Hernández F, Ramos-Garibay JA, González-González M, Berrezueta-Córdova NC, Osorio-Barboza JD

Language: Spanish
References: 10
Page: 12-17
PDF size: 435.82 Kb.


ABSTRACT

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLCL-LT) is characterized by diffuse, monotonous proliferation of centroblasts and immunoblasts. It belongs to the classification of primary cutaneous B-cell lymphomas. This variety is rare. The average diagnosis is nine months, early suspicion, being important for timely treatment and reducing the risk of complications. In this article we present the case of a 64-year-old male patient with PCDLCL-LT, with adequate response to treatment.


REFERENCES

  1. Villela-Segura U, Villalobos-Meza M, Salazar-Pachicano J. Manifestación atípica de un linfoma cutáneo difuso de células B grandes tipo pierna. Dermatol Rev Mex. 2021; 65: S27-S30. doi: 10.24245/dermatolrevmex.v65id.5415.

  2. Pinheiro CG, Cruz LCBD, Paz ARD, Trindade LC. Primary cutaneous B-cell lymphoma leg type: good response with the RADHAP 21 protocol. An Bras Dermatol. 2022; 97: 179-183. doi: 10.1016/j.abd.2020.09.014.

  3. Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, Cleven AHG et al. Genetic stability of driver alterations in primary cutaneous diffuse large B-cell lymphoma, leg type and their relapses: a rationale for the use of molecular-based methods for more effective disease monitoring. Cancers (Basel). 2022; 14: 5152. doi: 10.3390/cancers14205152.

  4. Vitiello P, Sica A, Ronchi A, Caccavale S, Franco R, Argenziano G. Primary cutaneous B-cell lymphomas: an update. Front Oncol. 2020; 10: 651. doi: 10.3389/fonc.2020.00651.

  5. Uribe-Franco RC, Puebla-Miranda M. Prevalencia de linfoma cutáneo atendido en el servicio de dermatología de un hospital de segundo nivel en México. Med Int Méx. 2022; 38: 526-537. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2022/mim223f.pdf

  6. González GKI, Alcalá PD, Medina BA, Torres GS. Epidemiología de linfoma cutáneo en el Servicio de Dermatooncología del Centro Dermatológico "Pascua": experiencia de 20 años. Dermatología CMQ. 2008; 6: 221-226.

  7. Krenitsky A, Klager S, Hatch L, Sarriera-Lazaro C, Chen PL, Seminario-Vidal L. Update in diagnosis and management of primary cutaneous B-cell lymphomas. Am J Clin Dermatol. 2022; 23: 689-706. doi: 10.1007/s40257-022-00704-0.

  8. Zehnder M, Amarov B, Abrunhosa-Branquinho AN, Maiwald-Urosevic M, Mühleisen B, Saulite I et al. Radiotherapy as a treatment option for local disease control in primary cutaneous diffuse large B-cell lymphoma, leg type. Dermatology. 2022; 238: 967-976. doi: 10.1159/000522053.

  9. Behera B, Palit A, Nayak AK, Panigrahi A, Mishra P, Sethy M. Clinico-dermoscopic-pathological features of a rare case of locally invasive multifocal primary cutaneous diffuse large B cell lymphoma-leg type over the face and scalp. Indian J Dermatol. 2022; 67: 283-286. doi: 10.4103/ijd.IJD_783_20.

  10. Vences-Carranza M, Navarrete-Franco G, González-González M, Ramos-Garibay A, Álvarez-Gallegos V, Ortiz-Ávalos M. Linfoma B cutáneo de células grandes de la pierna. Dermatol Rev Mex. 2012; 56: 66-70.




2020     |     www.medigraphic.com